Mydecine Innovations Group (XCNQ:MYCO) Total Long-Term Assets : C$0.00 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Mydecine Innovations Group's Total Long-Term Assets for the quarter that ended in Sep. 2024 was C$0.00 Mil.

Mydecine Innovations Group Total Long-Term Assets Historical Data

The historical data trend for Mydecine Innovations Group's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Total Long-Term Assets Chart

Mydecine Innovations Group Annual Data

Trend

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Long-Term Assets

Get a 7-Day Free Trial

1.46

7.04

2.36

0.69

Mydecine Innovations Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Long-Term Assets	Get a 7-Day Free Trial															0.49	-	-	-	-

Mydecine Innovations Group Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Mydecine Innovations Group Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (XCNQ:MYCO) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

MYCOF:USA 0NF0:Germany

Address

1890 – 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Executives

David Joshua Bartch	Director
Damon Michaels	Senior Officer
Michael Connolly	Director

Mydecine Innovations Group Headlines

No Headlines